LH can cross-react with some assays for hCG. Administration of supplemental testosterone reduces the release of gonadotropin-releasing hormone and consequently suppresses pituitary production of LH ...

Background: Since 2014, adaptation of chemotherapy based on tumor marker decline after the cycle of BEP (Bleomycin, Etoposide, Cisplatin) is a standard for patients with IGCCCG poor-risk NSGCT based ...

Tumor M2 Pyruvate Kinase: A Tumor Marker and its Clinical Application in Gastrointestinal Malignancy. Philip D. Hardt, MD, PhD; Nils Ewald, MD. Disclosures. Expert Rev Mol Diagn. 2008;8(5):579-585.

A new report suggests Samsung could lock advanced coaching tools behind a subscription, leaving older Galaxy Watch owners to ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous squamous cell carcinoma (cSCC), the most common type of metastatic skin cancer.

Cofounder and president of MyHealthTeam and Swoop chief patient officer Eric Peacock reveals how listening to patient voices ...

Protecting fertility rights. For generations, treating cervical cancer meant sacrificing fertility—a devastating consequence for young women. In 2006, Professor Wu Xiaohua and his team performed ...

J&J has identified KLK2 as the most selective prostate cancer marker. While PSMA is found in the salivary glands, leading to adverse events in recipients of medicines such as Novartis ...